-
Je něco špatně v tomto záznamu ?
Acute exposure to long-chain fatty acids impairs {alpha}2-adrenergic receptor-mediated antilipolysis in human adipose tissue
J Polak, C Moro, D Bessiere, J Hejnova, MA Marques, M Bajzova, M Lafontan, F Crampes, M Berlan, V Stich
Jazyk angličtina Země Spojené státy americké
NLK
Free Medical Journals
od 1959 do Před 1 rokem
Freely Accessible Science Journals
od 1959
Open Access Digital Library
od 1959-10-01
ROAD: Directory of Open Access Scholarly Resources
od 1959
- MeSH
- alfa-2-adrenergní receptory metabolismus MeSH
- dietní tuky MeSH
- dospělí MeSH
- fentolamin farmakologie MeSH
- financování organizované MeSH
- inzulin metabolismus MeSH
- lidé středního věku MeSH
- lidé MeSH
- lipolýza MeSH
- mastné kyseliny metabolismus MeSH
- mikrodialýza MeSH
- obezita MeSH
- potraviny MeSH
- tuková tkáň metabolismus MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
The acute in vitro and in vivo effects of long-chain fatty acids (LCFAs) on the regulation of adrenergic lipolysis were investigated in human adipose tissue. The effect of a 2 h incubation, without or with LCFA (200 mumol/l), on basal and hormonally induced lipolysis was tested in vitro on isolated fat cells. The lipolytic response to epinephrine was enhanced by suppression of the antilipolytic alpha(2)-adrenergic effect. Then, healthy lean and obese male subjects performed a 45 min exercise bout at 50% of their heart rate reserve either after an overnight fast or 3 h after a high-fat meal (HFM: 95% fat, 5% carbohydrates). Subcutaneous adipose tissue lipolysis was measured by microdialysis in the presence or absence of an alpha-antagonist (phentolamine). In vivo, a HFM increased plasma levels of nonesterified fatty acids in lean and obese subjects. In both groups, the HFM did not alter hormonal responses to exercise. Under fasting conditions, the alpha(2)-adrenergic antilipolytic effect was more pronounced in obese than in lean subjects. The HFM totally suppressed the alpha(2)-adrenergic antilipolytic effect in lean and obese subjects during exercise. LCFAs per se, in vitro as well as in vivo, suppress alpha(2)-adrenergic-mediated antilipolysis in adipose tissue. LCFA-mediated suppression of antilipolytic pathways represents another mechanism whereby a high fat content in the diet might increase adipose tissue lipolysis.
Citace poskytuje Crossref.org
- 000
- 03286naa 2200493 a 4500
- 001
- bmc10012720
- 003
- CZ-PrNML
- 005
- 20121113100420.0
- 008
- 100526s2007 xxu e eng||
- 009
- AR
- 024 __
- $a 10.1194/jlr.m700253-jlr200 $2 doi
- 035 __
- $a (PubMed)17625217
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Polák, Jan $7 xx0102455
- 245 10
- $a Acute exposure to long-chain fatty acids impairs {alpha}2-adrenergic receptor-mediated antilipolysis in human adipose tissue / $c J Polak, C Moro, D Bessiere, J Hejnova, MA Marques, M Bajzova, M Lafontan, F Crampes, M Berlan, V Stich
- 314 __
- $a Franco-Czech Laboratory for Clinical Research on Obesity, French Institute of Health and Medical Research (Institut National de la Sante et de la Recherche Medicale U858), Charles University in Prague, Prague, Czech Republic.
- 520 9_
- $a The acute in vitro and in vivo effects of long-chain fatty acids (LCFAs) on the regulation of adrenergic lipolysis were investigated in human adipose tissue. The effect of a 2 h incubation, without or with LCFA (200 mumol/l), on basal and hormonally induced lipolysis was tested in vitro on isolated fat cells. The lipolytic response to epinephrine was enhanced by suppression of the antilipolytic alpha(2)-adrenergic effect. Then, healthy lean and obese male subjects performed a 45 min exercise bout at 50% of their heart rate reserve either after an overnight fast or 3 h after a high-fat meal (HFM: 95% fat, 5% carbohydrates). Subcutaneous adipose tissue lipolysis was measured by microdialysis in the presence or absence of an alpha-antagonist (phentolamine). In vivo, a HFM increased plasma levels of nonesterified fatty acids in lean and obese subjects. In both groups, the HFM did not alter hormonal responses to exercise. Under fasting conditions, the alpha(2)-adrenergic antilipolytic effect was more pronounced in obese than in lean subjects. The HFM totally suppressed the alpha(2)-adrenergic antilipolytic effect in lean and obese subjects during exercise. LCFAs per se, in vitro as well as in vivo, suppress alpha(2)-adrenergic-mediated antilipolysis in adipose tissue. LCFA-mediated suppression of antilipolytic pathways represents another mechanism whereby a high fat content in the diet might increase adipose tissue lipolysis.
- 650 _2
- $a tuková tkáň $x metabolismus $7 D000273
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a dietní tuky $7 D004041
- 650 _2
- $a mastné kyseliny $x metabolismus $7 D005227
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a potraviny $7 D005502
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inzulin $x metabolismus $7 D007328
- 650 _2
- $a lipolýza $7 D008066
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mikrodialýza $7 D017551
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a obezita $7 D009765
- 650 _2
- $a fentolamin $x farmakologie $7 D010646
- 650 _2
- $a alfa-2-adrenergní receptory $x metabolismus $7 D018341
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Moro, Cedric
- 700 1_
- $a Bessiere, David
- 700 1_
- $a Hejnová, Jindra, $d 1947- $7 nlk20040147074
- 700 1_
- $a Marques, Marie A.
- 700 1_
- $a Bajzová, Magda, $d 1981- $7 xx0065865
- 700 1_
- $a Lafontan, Max
- 700 1_
- $a Crampes, Francois
- 700 1_
- $a Berlan, Michel
- 700 1_
- $a Štich, Vladimír, $d 1946- $7 xx0050390
- 773 0_
- $t Journal of Lipid Research $w MED00002766 $g Roč. 48, č. 10 Oct (2007), s. 2236-2246 $x 0022-2275
- 910 __
- $a ABA008 $b x $y 8
- 990 __
- $a 20100531141815 $b ABA008
- 991 __
- $a 20121113100435 $b ABA008
- 999 __
- $a ok $b bmc $g 726575 $s 589732
- BAS __
- $a 3
- BMC __
- $a 2007 $b 48 $c 10 Oct $d 2236-2246 $i 0022-2275 $m Journal of lipid research $n J Lipid Res $x MED00002766
- LZP __
- $a 2010-B2/vtme